Evaluation of Synergetic Anticancer Activity of Berberine and Curcumin on Different Models of A549, Hep-G2, MCF-7, Jurkat, and K562 Cell Lines

Table 3

Final stock concentrations used in the study.

S. number	Test item name	Final stock in DMEM in mg/mL	Final working stock concentration in RPMI in mg/mL	Volume of working stock in mL	Volume of DMEM in mL
1	Berberine + Curcumin (BECU)	1.25 (4-fold)	0.313, 0.078, 0.020, 0.005, 0.001	1.25 mL	3.75 mL
2	Curcumin (CU)	1.25 (4-fold)	0.313, 0.078, 0.020, 0.005, 0.001	1.25 mL	3.75 mL
3	(Berberine) BE	0.5 (3-fold)	0.16, 0.0565, 0.019, 0.006, 0.002	1.67 mL	3.33 mL